CRYOPORT, INC. Debt Instrument, Redemption Price, Percentage
CRYOPORT, INC. (CYRX) reported Debt Instrument, Redemption Price, Percentage of 106.00% for the 0-month period ending 2020-12-14, per its 10-K filed 2020-03-10.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentRedemptionPricePercentage · last filed 2020-03-10
- 2020-12-14: Debt Instrument, Redemption Price, Percentage 0 month 106.00%; Debt Instrument, Redemption Price, Percentage 106.00%.
- 2020-12-13: Debt Instrument, Redemption Price, Percentage 0 month 109.00%; Debt Instrument, Redemption Price, Percentage 109.00%.
- 2019-12-14: Debt Instrument, Redemption Price, Percentage 0 month 112.00%; Debt Instrument, Redemption Price, Percentage 112.00%.
| Period end | Debt Instrument, Redemption Price, Percentage 0 month | Debt Instrument, Redemption Price, Percentage |
|---|---|---|
| 2020-12-14 | 106.00% 10-K · filed 2020-03-10 | 106.00% 10-Q · filed 2019-11-12 |
| 2020-12-13 | 109.00% 10-K · filed 2020-03-10 | 109.00% 10-Q · filed 2019-11-12 |
| 2019-12-14 | 112.00% 10-K · filed 2020-03-10 | 112.00% 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |